Trial intelligence / Profile preview

Fecal Transplantation vs Vancomycin Taper for Recurrent CDI

NCT01226992Phase 3Terminated

Sponsor
University Health Network
Start
Oct 2010
Primary completion
Oct 2014
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 3 trial of Fecal Microbiota Transplantation Capsule in Clostridioides difficile infection (CDI), sponsored by University Health Network. Started Oct 2010; status: terminated.

02

Drugs

Fecal Microbiota Transplantation Capsule
03

Conditions

Clostridioides difficile infection (CDI)

Beyond the preview

Go deeper on NCT01226992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01226992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call